Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality - PubMed (original) (raw)
Comparative Study
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality
M Tersmette et al. Lancet. 1989.
Abstract
49 individuals seropositive for human immunodeficiency virus (HIV) antibody were studied longitudinally for the relation between in-vitro properties of their sequential HIV isolates and clinical course before and after the development of AIDS. They were classified into three groups according to the syncytium-inducing capacity, replication rate, and host range of their HIV isolates. The most rapid progression to AIDS (median 15 months) and the lowest survival rate following AIDS diagnosis (median survival 12.5 months) were observed in individuals with high-replicating, syncytium-inducing HIV isolates, followed by individuals with high-replicating, non-syncytium-inducing isolates. In contrast, most individuals with low-replicating, non-syncytium-inducing HIV isolates remained symptom-free during the study period (median follow-up until AIDS diagnosis greater than 42 months), and the few individuals from this group in whom AIDS developed were still alive at the end of the study period (median survival greater than 34 months). In addition, AIDS patients from the three groups differed with respect to their symptoms. Zidovudine treatment in the symptom-free period seemed to delay the onset of AIDS in all risk groups, although stabilisation of CD4+ cell numbers was observed only in individuals with non-syncytium-inducing HIV variants.
Similar articles
- Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, Goudsmit J, Huisman HG, Miedema F. Tersmette M, et al. J Virol. 1989 May;63(5):2118-25. doi: 10.1128/JVI.63.5.2118-2125.1989. J Virol. 1989. PMID: 2564898 Free PMC article. - Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
Tersmette M, de Goede RE, Al BJ, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F. Tersmette M, et al. J Virol. 1988 Jun;62(6):2026-32. doi: 10.1128/JVI.62.6.2026-2032.1988. J Virol. 1988. PMID: 3130494 Free PMC article. - Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
Connor RI, Ho DD. Connor RI, et al. J Virol. 1994 Jul;68(7):4400-8. doi: 10.1128/JVI.68.7.4400-4408.1994. J Virol. 1994. PMID: 7515972 Free PMC article. - Mysteries of HIV: challenges for therapy and prevention.
Levy JA. Levy JA. Nature. 1988 Jun 9;333(6173):519-22. doi: 10.1038/333519a0. Nature. 1988. PMID: 3287174 Review. - Human immunodeficiency viruses.
[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risks Hum. 1996;67:31-259. IARC Monogr Eval Carcinog Risks Hum. 1996. PMID: 9103966 Free PMC article. Review. No abstract available.
Cited by
- Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.
Liu L, Dong A, Liao L, Feng Y, Shao Y, Liang S, Ruan Y, Xing H. Liu L, et al. Curr HIV Res. 2019;17(6):441-451. doi: 10.2174/1570162X17666191128101426. Curr HIV Res. 2019. PMID: 31778107 Free PMC article. - Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers.
Casado C, Marrero-Hernández S, Márquez-Arce D, Pernas M, Marfil S, Borràs-Grañana F, Olivares I, Cabrera-Rodríguez R, Valera MS, de Armas-Rillo L, Lemey P, Blanco J, Valenzuela-Fernández A, Lopez-Galíndez C. Casado C, et al. mBio. 2018 Apr 10;9(2):e02338-17. doi: 10.1128/mBio.02338-17. mBio. 2018. PMID: 29636433 Free PMC article. - Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.
Hayashida T, Tsuchiya K, Kikuchi Y, Oka S, Gatanaga H. Hayashida T, et al. PLoS One. 2017 May 4;12(5):e0177033. doi: 10.1371/journal.pone.0177033. eCollection 2017. PLoS One. 2017. PMID: 28472121 Free PMC article. - Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.
Beauparlant D, Rusert P, Magnus C, Kadelka C, Weber J, Uhr T, Zagordi O, Oberle C, Duenas-Decamp MJ, Clapham PR, Metzner KJ, Günthard HF, Trkola A. Beauparlant D, et al. PLoS Pathog. 2017 Mar 6;13(3):e1006255. doi: 10.1371/journal.ppat.1006255. eCollection 2017 Mar. PLoS Pathog. 2017. PMID: 28264054 Free PMC article. - Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.
Choi WT, Yang Y, Xu Y, An J. Choi WT, et al. Curr Top Med Chem. 2014;14(13):1574-89. doi: 10.2174/1568026614666140827143541. Curr Top Med Chem. 2014. PMID: 25159167 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials